H
Hamzavi Dermatology | Canton
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Relugolix
TNX-102
Estradiol
JNJ-77242113
Norethindrone Acetate
Parent organization
This site is a part of Hamzavi Dermatology
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 9 total trials
The purpose of the study is to evaluate how effective JNJ-77242113 is in participants with moderate to severe plaque psoriasis compared to placebo an...
Active, not recruiting
Plaque Psoriasis
Drug: Deucravacitinib Matching Placebo
Drug: JNJ-77242113 Matching Placebo
To evaluate repigmentation and quality of life after treatment of stable vitiligo lesions using the RECELL Device.
Active, not recruiting
Vitiligo
Device: RECELL® Autologous Cell Harvesting Device
Trial sponsors
M
A
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems